US Dermal Fillers Market Overview
US Dermal Fillers Market Size was valued at USD 2.4 Billion in 2022. The industry is projected to grow from USD 2.67 Billion in 2023 to USD 6.39 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.50% during the forecast period (2023 - 2032). A growing aging population, increasing aesthetic consciousness, and advancements in dermal filler technologies are the key market drivers enhancing market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Dermal Fillers Market Trends
- Increasing non-surgical cosmetic procedures is propelling market growth
Dermal filler treatments are increasingly favored for their long-lasting effects and natural appearance. There is a growing trend among patients to prefer advanced formulations that offer prolonged results in order to achieve subtle enhancements. This phenomenon is propelled by an aesthetic preference for treatments that harmoniously blend in with an individual's inherent features, signifying a departure from more conspicuous cosmetic interventions. In response, the market introduces novel infill products that exhibit enhanced biocompatibility and prolonged durability, thereby satisfying the market's desire for aesthetically pleasing solutions that combine effectiveness and subtlety.
Furthermore, the utilization of non-invasive cosmetic procedures is on the rise, which contributes to the expansion of the dermal fillers as a whole. Dermal fillers are gaining popularity as an increasing number of individuals opt for minimally invasive alternatives to conventional surgical procedures in order to address various concerns, including volume loss, wrinkles, and facial contouring. Non-surgical procedures are gaining popularity due to their inherent advantages of convenience, shortened recovery periods, and reduced risks. Furthermore, the desire for immediate and conspicuous outcomes, coupled with the impact of social media, contributes to the increasing prevalence of dermal fillers within the dynamic realm of aesthetic procedures in the United States. Thus driving the revenue.
Dermal Fillers Market Segment Insights
Dermal Fillers Material Insights
The segmentation, based on Material, includes Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid, PMMA (Poly (methyl methacrylate), Fat Fillers, and Others. Hyaluronic acid constitutes the most substantial segment within the dermal fillers market in the United States. The factor contributing to its predominance is its inherent presence within the body, which ensures biocompatibility and diminishes the likelihood of adverse reactions. Additional factors contributing to hyaluronic acid's widespread use are its capacity to augment volume, diminish wrinkles, and provide transient yet impactful outcomes.
Dermal Fillers Product Insights
The segmentation, based on Product, includes Biodegradable and Non-biodegradable. The market for biodegradable dermal fillers is the most substantial segment in the United States, primarily attributed to the increasing demand for transient and reversible cosmetic improvements. The ability of patients to modify or terminate treatments is valued, as it corresponds with the dynamic nature of cosmetic preferences.
Figure 1: US Dermal Fillers Market, by Product, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Dermal Fillers Application Insights
The segmentation, based on Application, includes Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others. The market for dermal fillers in the United States is dominated by wrinkle correction treatment, which is propelled by the widespread aspiration for a more youthful aesthetic. As the proportion of the elderly population increases, people increasingly look for non-invasive methods to treat wrinkles and other evidence of aging. Dermal fillers' notable expansion in this market segment is propelled by their efficacy in diminishing wrinkles and reinstating skin elasticity.
Dermal Fillers End-user Insights
The segmentation, based on the End-user, includes Specialty & Dermatology Clinics, Hospitals & Clinics, and Others. The largest market segment for dermal fillers in the United States is comprised of specialty and dermatology clinics, which are distinguished by their exclusive emphasis on aesthetic treatments. These clinics specialize in the application of dermal fillers, which appeal to individuals in search of aesthetic improvements. Significant growth in this sector is attributable to the devoted approach of specialty clinics and their proficient practitioners.
Dermal Fillers Key Market Players & Competitive Insights
Leading market players in the United States utilize mergers, partnerships, and product innovation as a means of gaining a competitive advantage. Organizations prioritize market developments such as the growth of their product lines and the improvement of their market standing by means of strategic alliances. The Dermal Fillers industry dynamics are influenced by shifting consumer preferences, technological progress, and the prioritization of safety and effectiveness. This reflects a competitive environment that is adaptable to the evolving aesthetic procedures sector.
Key Companies in the Dermal Fillers market include
- Allergan Aesthetics (AbbVie Inc.) (U.S.)
- Revance Therapeutics, Inc. (U.S.)
- GALDERMA (Switzerland)
- Suneva Medical (U.S.)
- Prollenium Medical Technologies (Canada)
- Bioxis Pharmaceuticals (France)
- Merz Pharma (Germany)
- Sinclair (U.K.)
Dermal Fillers Market Segmentation
Dermal Fillers Material Outlook
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Poly-L-Lactic Acid
- PMMA (Poly (methyl methacrylate))
- Fat Fillers
- Others
Dermal Fillers Product Outlook
- Biodegradable
- Non-biodegradable
Dermal Fillers Application Outlook
- Scar Treatment
- Wrinkle Correction Treatment
- Lip Enhancement
- Restoration of Volume/Fullness
- Others
Dermal Fillers End-user Outlook
- Specialty & Dermatology Clinics
- Hospitals & Clinics
- Others
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 2.4 Billion |
Market Size 2023 |
USD 2.67 Billion |
Market Size 2032 |
USD 6.39 Billion |
Compound Annual Growth Rate (CAGR) |
11.50% (2023-2032) |
Base Year |
2022 |
Market Forecast Period |
2023-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Material, Product, Application, End-user, and Region |
Key Companies Profiled |
 Allergan Aesthetics (AbbVie Inc.) (U.S.), Revance Therapeutics, Inc. (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Suneva Medical (U.S.), Prollenium Medical Technologies (Canada), Bioxis pharmaceuticals (France), and Sinclair (U.K.) |
Key Market Opportunities |
·      Growing demographic seeking cosmetic enhancements. ·      Ongoing R&D leading to improved dermal filler formulations. |
Key Market Dynamics |
·      Shift towards minimally invasive and reversible solutions. ·      Increased demand for expertise in aesthetic treatments. |
Frequently Asked Questions (FAQ) :
The US Dermal Fillers market size was valued at USD 2.4 Billion in 2022.
The US market is projected to grow at a CAGR of 11.50% during the forecast period, 2023-2032.
North America had the largest share in the US market
The key players in the market are Allergan Aesthetics (AbbVie Inc.) (U.S.), Revance Therapeutics, Inc. (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Suneva Medical (U.S.), Prollenium Medical Technologies (Canada), Bioxis pharmaceuticals (France), and Sinclair (U.K.).
The Hyaluronic acid dominated the market in 2022.
The biodegradable dermal fillers had the largest share in the US market.